414
Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab .
 adverse effect: macrophagic activation syndrome, adalimumab; adverse effect: Visceral leishmaniasis, adalimumab
Given options, please tell me the relationships of all the listed entity pairs.Output format is "relation1: word1, word2; relation2: word3, word4". 
Option: adverse effect 
Text: {0} 
 Entity Pairs:  macrophagic activation syndrome, adalimumab; Visceral leishmaniasis, adalimumab 
Answer:
 adverse effect: macrophagic activation syndrome, adalimumab; adverse effect: Visceral leishmaniasis, adalimumab